Αρχική World News Metastasis Likely Caused by Lack of Oxygen in Cancerous Tumors, Study Shows

Metastasis Likely Caused by Lack of Oxygen in Cancerous Tumors, Study Shows

Metastatic cancer refers to cancer that has spread from its original location to other parts of the body. This process occurs when cancer cells break away from the original tumor and travel through the bloodstream or the lymphatic system to another area of the body. If the new location these cells take up residence in is a vital organ—such as the brain, liver, bones, or lungs—they can become deadly and very difficult to treat.Circulating tumor cells (CTCs) have been shown to be the cause of metastasis, so if we could keep these cells from breaking off of the original tumor, we could keep metastasis from taking place and save lives. But how?According to a new study from the University of Basel, a lack of oxygen may be causing the separation of CTC clusters from their tumors, resulting in metastasis.Photo: Adobe Stock/Christoph BurgstedtThe study, called “Hypoxia Triggers the Intravasation of Clustered Circulating Tumor Cells,” has been published in the journal Cell Reports. Nicola Aceto, PhD, Swiss National Science Foundation assistant professor and group leader of the Cancer Metastasis Lab at the University of Basel, led the study.The team used a mouse model to analyze the oxygen supply inside of breast cancer tissues, the detachment of CTCs, and the molecular and biological properties of those CTCs. They found that different areas of the same tumor were supplied with different amounts of oxygen. Those cancer cells that were located in areas with the least oxygen were the most likely to break away.“It’s as though too many people are crowded together in a small space,” explains Dr. Aceto. “A few will go outside to find some fresh air.”Photo: Adobe Stock/crevisThe team also learned that the CTC clusters with low oxygen supply (known as “hypoxia“) formed metastases faster and shortened the mice’s survival time more than the CTC clusters with normal oxygen content.“In a tumor, hypoxia is generally expected to be confined to the core and within regions that are poorly vascularized. However, this is an apparent paradox in the context of metastasis biology because metastatic cancer cells need to have access to functional blood vessels to achieve dissemination. We thought of tackling this controversy by directly addressing the role of hypoxia in spontaneous metastasis models in vivo and in relation to CTC generation and metastasis,” the study says.The researchers then created a simulated formation of blood vessels in order to boost the oxygen levels supplied to the tumor cells. As expected, increasing the oxygen supply caused fewer CTC clusters to break off, which resulted in fewer metastases and overall longer-living mice. However, the original tumor thrived with increased oxygen and grew more quickly.Photo: Adobe Stock/romaset“This is a provocative result,” says Aceto. “If we give the tumor enough oxygen, the cancer cells have no reason to leave the tumor and metastasize. On the other hand, this accelerates the growth of the primary tumor.”The researchers look forward to applying their findings in a clinical setting to see how the characteristics of cancer vary from patient to patient. In the future, their research will hopefully be applied to treatment strategies to help improve the way we treat cancer.“We speculate that therapies aimed at reducing intra-tumor hypoxia, alone or in combination with anticancer agents, may provide a new opportunity to blunt the metastatic spread of cancer in breast cancer patients,” the study concludes.We can’t wait to see what happens next! This could be an absolute game-changer in the prevention of metastatic cancer!Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

Study Finds Most Women Who ‘Go Flat’ After Mastectomy Are Happy with the Decision

Getting a mastectomy during breast cancer treatment is a very life-changing and stressful thing, often made more concerning when faced with what to do...

New Research in Treating Leukemia and Lymphoma: ASH Annual Meeting 2020

The 2020 American Society of Hematology (ASH) Annual Meeting and Exposition was held virtually December 5 to 8. The meeting featured new research around...

Understanding Serving Sizes

Use these tips and nutritional information when thinking about serving sizes. Paige Dietz is a student dietetics volunteer at the Penn Abramson Cancer Center. She...

Adjuvant Therapy with Oxaliplatin Added to Fluoropyrimidine Improves Survival in Patients with MSI/dMMR Stage III Colon Cancer

A large analysis of data from twelve trials evaluating the efficacy of adjuvant fluoropyrimidine with or without oxaliplatin in patients with stage III colon...

Discovering the BRCA2 gene – 25 years on

A breast cancer cell. Credit: LRI EM Unit. 25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off. “You...

Bowel scope screening to stop in England

<img width="620" height="348" src="https://zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com/wp-content/uploads/2018/10/bowel-immunohistochemistry-4.jpg" class="attachment-featuredImage size-featuredImage" alt="Section of human colon showing sausage-shaped crypts." loading="lazy" srcset="https://zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com/wp-content/uploads/2018/10/bowel-immunohistochemistry-4.jpg 620w, https://zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com/wp-content/uploads/2018/10/bowel-immunohistochemistry-4-300x168.jpg 300w, https://zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com/wp-content/uploads/2018/10/bowel-immunohistochemistry-4-220x123.jpg 220w" sizes="(max-width: 620px) 100vw, 620px"...